FFM
Fairmount Funds Management Portfolio holdings
AUM
$772M
This Quarter Return
+24.01%
1 Year Return
+35.05%
3 Year Return
+1,168.51%
5 Year Return
+1,432.11%
10 Year Return
–
AUM
$280M
AUM Growth
+$280M
(+18%)
Cap. Flow
-$62.5M
Cap. Flow
% of AUM
-22.34%
Top 10 Holdings %
Top 10 Hldgs %
80.43%
Holding
20
New
3
Increased
1
Reduced
9
Closed
2
Top Buys
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$9.31M |
| 2 |
Seres Therapeutics
MCRB
|
$6.3M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$5.6M |
| 4 |
Viridian Therapeutics
VRDN
|
$554K |
Top Sells
| 1 |
Cogent Biosciences
COGT
|
$52.5M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$10.6M |
| 3 |
Neurogene
NGNE
|
$4.47M |
| 4 |
Kiniksa Pharmaceuticals
KNSA
|
$3.26M |
| 5 |
Amicus Therapeutics
FOLD
|
$3.23M |
Sector Composition
| 1 | Healthcare | 92.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$28.8B
| $32M | 11.45% | 961,797 -95,000 | -9% | -$3.16M |
|
|
2
Amicus Therapeutics
FOLD
$2.34B
| $30.4M | 10.86% | 1,315,395 -140,000 | -10% | -$3.23M |
|
3
Iovance Biotherapeutics
IOVA
$807M
| $26.3M | 9.39% | 565,890 -31,000 | -5% | -$1.44M |
|
|
4
Acadia Pharmaceuticals
ACAD
$4.38B
| $24.1M | 8.61% | 450,317 -197,516 | -30% | -$10.6M |
|
|
TRIL
5
DELISTED
Trillium Therapeutics Inc.
TRIL
| $21.7M | 7.78% | 1,478,181 -80,000 | -5% | -$1.18M |
|
|
ALLK
6
DELISTED
Allakos
ALLK
| $20.7M | 7.39% | 147,662 -17,000 | -10% | -$2.38M |
|
|
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
| $19.6M | 7.01% | 980,645 -76,230 | -7% | -$1.52M |
|
8
Axsome Therapeutics
AXSM
$6.05B
| $17.9M | 6.41% | 220,098 | – | – |
|
|
9
Cogent Biosciences
COGT
$1.69B
| $17.5M | 6.26% | 1,558,975 -4,676,928 | -75% | -$52.5M |
|
10
argenx
ARGX
$43.6B
| $14.7M | 5.25% | 49,950 | – | – |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.3M | 4.75% | 60,500 +25,500 | +73% | +$5.6M |
|
12
Karyopharm Therapeutics
KPTI
$61.7M
| $10.9M | 3.89% | 702,351 | – | – |
|
|
GBT
13
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $9.31M | 3.33% | +215,000 | New | +$9.31M |
|
|
AMRN
14
Amarin Corp
AMRN
$311M
| $7.38M | 2.64% | 1,508,237 | – | – |
|
15
Enanta Pharmaceuticals
ENTA
$180M
| $6.33M | 2.27% | 150,433 -11,803 | -7% | -$497K |
|
|
16
Seres Therapeutics
MCRB
$166M
| $6.3M | 2.25% | +257,016 | New | +$6.3M |
|
|
VRNA
17
Verona Pharma
VRNA
$9.16B
| $700K | 0.25% | 100,000 | – | – |
|
|
18
Viridian Therapeutics
VRDN
$1.5B
| $554K | 0.2% | +35,092 | New | +$554K |
|
|
19
Kiniksa Pharmaceuticals
KNSA
$2.48B
| – | – | -212,746 | Closed | -$3.26M |
|
|
20
Neurogene
NGNE
$264M
| – | – | -372,748 | Closed | -$4.47M |
|